Market Research Reports - Ken Research Kuwait Pharmaceuticals Market Outlook to 2022 | Page 3

for development of the healthcare sector through the public-private partnership (PPP) route is
expected to grow the pharmaceuticals market too in the coming years. The availability of
generic products is anticipated to increase as private health insurance schemes are encouraging
prescribers to adopt more rational prescription patterns. As Kuwait accelerates its healthcare
development strategy as part of the Kuwait Vision 2035, both Kuwait's pharmaceutical and
healthcare markets have been noted as high-priority sectors, with many projects set to be
carried out under public-private partnerships (PPPs). Furthermore, chronic diseases such as
cardiovascular, diabetes, obesity, cancer and respiratory conditions are rising dramatically in
Kuwait primarily due to less physical activity and dietary habits such as increased fast food
consumption linked to high-income generation. Thus the market shares of anti-infective,
gastrointestinal, cardiovascular and musculoskeletal are expected to increase in the Kuwait
pharmaceuticals market by 2022.
Key Segments Covered
By Type of Drug
Generic Drugs
Patented Drugs
By OTC and Prescription Drugs
OTC Drugs
Prescription Drugs
By End Users
Public Sector
Private Sector
By Channel of Distribution
Institutional Sales
Retail Sales
By Therapeutic Class
Anti-Infectives
Gastrointestinal